Skip to main content
ADMA logo

ADMA · Adma Biologics, Inc. · Metrics

Track ADMA — free
Market Cap
$2.96B
Shares
221.85M
Volume · Nov 20 284.76K Avg daily vol (3M) 3.2M

ADMA metrics

113 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.34
Market cap
$2.96B

Price action

23 metrics
Price change (1W)
+0.8%
Price change (30D)
+21.2%
Price change (3M)
+36.7%
Price change (6M)
+57.7%
Price change (YTD)
-26.9%
Price change (1Y)
-16.4%
Trailing year
Price change (5Y)
+771.9%
52-week high
$20.38
52-week low
$7.60
Change from 52-week high
-34.5%
Change from 52-week low
+75.5%
Annualized volatility
58.9%
Annualized volatility (3M)
64.3%
Implied volatility (30D)
50.4%
IV rank (1Y)
15.5
IV percentile (1Y)
11.4
Beta
-0.1
RSI (14D)
64.7
Price vs SMA 50
+22.4%
Price vs SMA 200
+25.2%
Avg volume (3M)
3.20M
Relative volume
1.1
Average dollar volume
$34.62M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
221.85M

Valuation

12 metrics
P / E (TTM)
17.3
Trailing earnings · reciprocal yield 5.8%
PEG ratio
0.4
EV / revenue
5.8×
reciprocal yield 17.1%
EV / EBITDA
12.2×
reciprocal yield 8.2%
EV / EBIT
12.6×
reciprocal yield 8.0%
P / sales
5.7×
reciprocal yield 17.5%
P / book
6.7
reciprocal yield 14.8%
FCF yield
4.5%
TTM · current market cap
Buyback yield
6.4%
P / FCF
22.3
reciprocal yield 4.5%
P / operating cash flow
21.0
reciprocal yield 4.8%
Earnings yield
6.2%

Historical valuation

8 metrics
P / E historical average (3Y)
31.6×
reciprocal yield 3.2%
P / E historical average (5Y)
31.6×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
5.7×
reciprocal yield 17.7%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 18.7%
EV / EBIT historical average (3Y)
14.4×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
14.4×
reciprocal yield 6.9%
EV / EBITDA historical average (3Y)
13.8×
reciprocal yield 7.2%
EV / EBITDA historical average (5Y)
13.8×
reciprocal yield 7.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
68.5%
Operating margin
46.5%
Trailing 12 months
Net margin
35.1%
Gross profit (TTM)
$355.76M
Operating profit (TTM)
$241.23M
Net income (TTM)
$182.41M
Trailing 12 months
Diluted EPS (TTM)
$0.77
FCF margin
25.6%
Effective tax rate
22.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$2.22
Gross profit per diluted share (TTM)
$1.52
Operating profit per diluted share (TTM)
$1.03
EBITDA per diluted share (TTM)
$1.06
Net income per diluted share (TTM)
$0.78
Operating cash flow per diluted share (TTM)
$0.60
Free cash flow per diluted share (TTM)
$0.56
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
$0.06
Stock compensation per diluted share (TTM)
$0.10
Book value per share
$2.01

Growth

11 metrics
Revenue growth YoY
+5.1%
Year over year
Net income growth YoY
+36.9%
Revenue (TTM)
$519.15M
Trailing 12 months
EPS growth YoY
+46.7%
Shares change YoY
-7.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+49.0%
Revenue CAGR (5Y)
+64.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
41.6%
Return on assets
24.9%
Debt / equity
0.4
Current ratio
6.0
EBITDA (TTM)
$248.68M
Free cash flow (TTM)
$132.91M
Quick ratio
3.3
Interest coverage
22.8
Net debt / EBITDA
0.3
Return on invested capital
36.8%
Trailing 12 months
Net cash
−$71.30M
Latest balance sheet
Cash & equivalents
$124.56M
Total assets
$732.49M
Total debt
$195.86M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$140.79M
Capital expenditures (TTM)
$7.88M
R&D (TTM)
$14.48M
SG&A (TTM)
$103.55M
Stock compensation (TTM)
$24.06M
R&D / revenue
2.8%
Stock compensation / revenue
4.6%

Ownership (13F)

9 metrics
13F filers
330
13F filer change QoQ
+8
Institutional ownership
90.5%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
31.3%
Private-fund adviser ownership
26.5%
Active holders' share change QoQ
+4.6%
Holder tenure
11.9
Price vs estimated holder cost
-14.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
34.7%

Short interest

3 metrics
Short interest
8.1%
Latest settlement · 7.1 days to cover
Days to cover
7.1d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.19M
Insider-sentiment score
46 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1368514 CUSIP 000899104 13F (30d) 333 filings 305 filers Visit website Investor relations